ABMD Financial Facts

Investment income (expense), net: 37K
Products: 46.14M
See Full Income Statement

Accrued expenses: 15.16M
Total stockholders' equity: 137.08M
See Full Balance Sheet

Abiomed Inc. (ABMD) Earnings

  |   Expand Research on ABMD
Next EPS Date 5/5/14 *Est. EPS Growth Rate +57.1% *Last Qtr.
Average EPS % Beat Rate -4.5% Revenue Growth Rate +20.6% *Last Qtr.
Average % Move 1-Wk after EPS +5.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
1/30/14 Q314 $0.11$0.05 +$0.06$46.2M$46M = -3.5% Details
11/6/13 Q214 $0.03$0.00 +$0.03$44.3M$43.75M = +3.6% Details
8/1/13 Q114 -$0.04$0.06 -$0.10$42.7M$42.93M = 0% Details
5/2/13 Q413 $0.09$0.07 +$0.02$43.7M$41.95M = +35.2% Details
2/6/13 Q313 $0.07$0.07 $0.00$38.3M$38.04M = +75.6% Details
11/1/12 Q213 $0.20$0.05 +$0.15$37.4M$37.47M = +27.6% Details
5/16/12 Q412 $0.13$0.06 +$0.07$37.3M$34.98M = +6.6% Details
2/3/12 Q312 $0.11-$0.01 +$0.12$32.2M$31.43M +31.5% Details